These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17196082)

  • 1. Application of heated inlet extensions to the TSI 3306/3321 system: comparison with the Andersen cascade impactor and next generation impactor.
    Myrdal PB; Mogalian E; Mitchell J; Nagel M; Wright C; Kiser B; Prell M; Woessner M; Stein SW
    J Aerosol Med; 2006; 19(4):543-54. PubMed ID: 17196082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers.
    Mogalian E; Myrdal PB
    Drug Dev Ind Pharm; 2005 Dec; 31(10):977-85. PubMed ID: 16316853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting the Abbreviated Impactor Measurement (AIM) concept to make appropriate inhaler aerosol measurements to compare with clinical data: a scoping study with the "Alberta" idealized throat (AIT) inlet.
    Mitchell J; Copley M; Sizer Y; Russell T; Solomon D
    J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):188-97. PubMed ID: 22857270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abbreviated impactor measurement (AIM) concept: part II--Influence of evaporation of a volatile component-evaluation with a "droplet-producing" pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent.
    Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
    AAPS PharmSciTech; 2009; 10(1):252-7. PubMed ID: 19291411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the TSI Model 3306 Impactor Inlet with the Andersen Cascade Impactor: solution metered dose inhalers.
    Myrdal PB; Stein SW; Mogalian E; Hoye W; Gupta A
    Drug Dev Ind Pharm; 2004 Sep; 30(8):859-68. PubMed ID: 15521331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.
    Kwong WT; Ho SL; Coates AL
    J Aerosol Med; 2000; 13(4):303-14. PubMed ID: 11262437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aiming for a moving target: challenges with impactor measurements of MDI aerosols.
    Stein SW
    Int J Pharm; 2008 May; 355(1-2):53-61. PubMed ID: 18191510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Electrostatic Controls on MDI Size Distribution Measurements.
    Stein SW; Rasmussen J; Walls S; Schultz DW; Oakley C; Drake JB
    AAPS PharmSciTech; 2019 Apr; 20(5):170. PubMed ID: 31004248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol.
    David Christopher J; Patel RB; Mitchell JP; Tougas TP; Goodey AP; Quiroz J; Andersson PU; Lyapustina S
    AAPS PharmSciTech; 2017 Nov; 18(8):3296-3306. PubMed ID: 28589305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations.
    Mitchell JP; Nagel MW
    J Aerosol Med; 2003; 16(4):341-77. PubMed ID: 14977427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of delivery characteristics from a combination metered-dose inhaler using the Andersen cascade impactor and the next generation pharmaceutical impactor.
    Guo C; Gillespie SR; Kauffman J; Doub WH
    J Pharm Sci; 2008 Aug; 97(8):3321-34. PubMed ID: 17932959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multi-laboratory in Vitro Study to Compare Data from Abbreviated and Pharmacopeial Impactor Measurements for Orally Inhaled Products: a Report of the European Aerosol Group (EPAG).
    Nichols SC; Mitchell JP; Sandell D; Andersson PU; Fischer M; Howald M; Pengilley R; Krüger P
    AAPS PharmSciTech; 2016 Dec; 17(6):1383-1392. PubMed ID: 26762338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers.
    Harris JA; Stein SW; Myrdal PB
    AAPS PharmSciTech; 2006 Mar; 7(1):E138-E145. PubMed ID: 28290035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
    Waldrep JC; Berlinski A; Dhand R
    J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size analysis of a pressurized metered dose inhaler-delivered solution formulation by an Aerosizer-LD time-of-flight aerosol particle size spectrometer.
    Nagel MW; Wiersema KJ; Bates SL; Mitchell JP
    J Aerosol Med; 2002; 15(1):75-85. PubMed ID: 12006148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers.
    Haynes A; Shaik MS; Krarup H; Singh M
    J Pharm Sci; 2004 Feb; 93(2):349-63. PubMed ID: 14705192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an abbreviated impactor for fine particle fraction (FPF) determination of metered dose inhalers (MDI).
    Guo C; Ngo D; Ahadi S; Doub WH
    AAPS PharmSciTech; 2013 Sep; 14(3):1004-11. PubMed ID: 23780781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation.
    Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
    AAPS PharmSciTech; 2009; 10(1):243-51. PubMed ID: 19280348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of droplet evaporation rate on resulting in vitro performance parameters of pressurized metered dose inhalers.
    Sheth P; Grimes MR; Stein SW; Myrdal PB
    Int J Pharm; 2017 Aug; 528(1-2):360-371. PubMed ID: 28599855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.